Product NewsThe Institute of Cancer Research UK advances quantitative immunohistochemistry capabilities using Ariol® image analysis system
Product NewsBioAlliance Pharma announces preliminary results of its Doxorubicin Transdrug® Phase I/II clinical trial for primary liver cancer
Product NewsUS Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint
Product NewsAblynx reveals power of Nanoclone™ - A high throughput method for isolating highly potent antibody-derived therapeutic proteins (Nanobodies™)